Current dividend yield | 4.98 % |
Dividendenrendite 5 Jahre | 4.27 % |
Dividend Yield 10Y | 1.9 % |
Payout 3Y | 8.24 % |
The iRadimed Corp stock dividend is paid 4 times a year. In order to receive a dividend, you should generally own the iRadimed Corp stock before the ex-dividend date. The Dividend Calendar shows that the last ex-day dates were , , and . Dividends from iRadimed Corp are distributed via , , and .
Year | Dividend | Ex-day & Payday |
Frequency | |
---|---|---|---|---|
Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
2024 |
$0.15
$0.15
|
Nov 15 2024
Nov 15 2024
Nov 25 2024
Nov 15 24
Nov 25 24 |
Nov 25 2024 |
quarterly
quarterly
|
2024 |
$0.15
$0.15
|
Aug 20 2024
Aug 20 2024
Aug 30 2024
Aug 20 24
Aug 30 24 |
Aug 30 2024 |
quarterly
quarterly
|
2024 |
$0.15
$0.15
|
May 17 2024
May 17 2024
May 30 2024
May 17 24
May 30 24 |
May 30 2024 |
quarterly
quarterly
|
2023 |
$0.15
$0.15
|
Dec 21 2023
Dec 21 2023
Jan 12 2024
Dec 21 23
Jan 12 24 |
Jan 12 2024 |
quarterly
quarterly
|
2023 |
$0.48
$0.48
|
Dec 21 2023
Dec 21 2023
Jan 12 2024
Dec 21 23
Jan 12 24 |
Jan 12 2024 |
Special dividend
Special div.
|
2023 |
$1.0389
$1.04
|
Feb 10 2023
Feb 10 2023
Feb 21 2023
Feb 10 23
Feb 21 23 |
Feb 21 2023 |
Special dividend
Special div.
|
2022 |
$0.96
$0.96
|
Feb 16 2022
Feb 16 2022
Feb 24 2022
Feb 16 22
Feb 24 22 |
Feb 24 2022 |
Special dividend
Special div.
|
iRadimed Corp most recently paid a dividend of $0.15. iRadimed Corp paid a Dividend of $0.00 Per Share in the financial year 2022. With a stock price of $54.06 at Nov 14 2024, the current dividend yield is 0.00% (calculation: $0.00 / $54.06 = 0.00%). A Special Dividend was paid in the amount of $0.96 Per Share. Special dividends are not included in the calculation of the dividend yield.
The average iRadimed Corp dividend yield over the last 5 years is 0.00% and the average over the last 10 years is 0.00%.
The payout ratio of iRadimed Corp in relation to the last financial year is 94.12%. The payout ratio smoothed over 3 years is 51.34%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
Metric | iRadimed Corp |
---|---|
Current dividend yield | 0.00% |
Dividend Yield 5Y | 0.00% |
Dividend Yield 10Y | 0.00% |
Payout 1Y | 94.12% |
Payout 3Y | 51.34% |
iRadimed Corp has been paying a dividend since 1 and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
Metric | iRadimed Corp |
---|---|
Increased | 1 Year |
Continuity | 1 Year |
Paid | 1 Year |
iRadimed Corp has been paying a dividend since 1 and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
On the stock exchange, the iRadimed Corp stock (ISIN: US46266A1097) is not traded as a top scorer in November 2024 according to the dividend strategy.
The stock price of iRadimed Corp 9.52% has risen since the beginning of the year 2024. However, the return generated in the past says nothing about the future return. You can find the iRadimed Corp stock price in real time at the top of the page.
iRadimed Corp (symbol: IRMD) is valued at a Price / Earnings Ratio (P/E ratio) of 37.02 and a price/sales ratio (P/S ratio) of 9.61 valued. Based on analyst estimates, the iRadimed Corp stock forecast 2024 of the current financial year corresponds to a valuation of 35.92 according to P/E ratio and 9.41 according to P/S.
Metric | iRadimed Corp |
---|---|
Dividend Score | ??/15 |
Performance 2024 |
9.52%
|
P/E TTM | 37.02 |
P/S TTM | 9.61 |
P/E forward | 35.92 |
P/S forward | 9.41 |
iRadimed Corp (symbol: IRMD) is valued at a Price / Earnings Ratio (P/E ratio) of 37.02 and a price/sales ratio (P/S ratio) of 9.61 valued. Based on analyst estimates, the iRadimed Corp stock forecast 2024 of the current financial year corresponds to a valuation of 35.92 according to P/E ratio and 9.41 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.